Chapter 1. OPIOID ANALGESICS AND ANTAGONISTS MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. OPIOID ANALGESICS AND ANTAGONISTS MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-110 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. OPIOID ANALGESICS AND ANTAGONISTS MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. OPIOID ANALGESICS AND ANTAGONISTS MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. OPIOID ANALGESICS AND ANTAGONISTS MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. OPIOID ANALGESICS AND ANTAGONISTS MARKET– By Drug Class

6.1. Buprenorphine

6.2. Codeine

6.3. Dextromethorphan

6.4. Fentanyl

6.5. Meperidine

6.6. Methadone

6.7. Morphine

6.8. Oxycodone

6.9. Tramadol

6.10. Others

Chapter 7. OPIOID ANALGESICS AND ANTAGONISTS MARKET– By Indication

7.1. Cancer Pain

7.2. Neuropathic Pain

7.3. Surgical Pain

7.4. Others

Chapter 8. OPIOID ANALGESICS AND ANTAGONISTS MARKET– By Route of Administration

8.1. Oral

8.2. Parental

8.3. Transdermal

8.4. Others

Chapter 9. OPIOID ANALGESICS AND ANTAGONISTS MARKET– By End User

9.1. Drug Stores

9.2. Hospitals

9.3. Online Pharmacies

9.4. Retail Pharmacies

Chapter 10. OPIOID ANALGESICS AND ANTAGONISTS MARKET– By Region

10.1. Retail Pharmacies

10.2. Online Pharmacies

10.3. Hospital Pharmacies

Chapter 11. OPIOID ANALGESICS AND ANTAGONISTS MARKET– By Region

11.1. North America

11.2. Europe

11.3. The Asia Pacific

11.4. Latin America

11.5. Middle-East and Africa

Chapter 10. OPIOID ANALGESICS AND ANTAGONISTS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10

Download Sample